JPMorgan Raised Its Share Increase Recommendation
JPMorgan raised its share increase recommendation. According to JPMorgan, vaccine news gives the markets a strong buy signal.
According to the news in Bloomberg HT, the vaccine announcements announced by JPMorgan strategists this week are 'groundbreaking' for the markets. While the heads of the three major central banks remain wary of vaccine developments, JPMorgan says positive vaccine news are giving markets a strong buying signal.
JPMorgan strategists decided to further reduce the position of government bonds while increasing the global equities position in the model portfolio. The note released by the strategists included the following statements:
“We think the stock rally and bond sales will continue. In the coming period, we maintain our pro-risk position in our model portfolio with our expectation of easing in significant market risks, moderate investor positioning, strong growth recovery and high level of policy support.”
JPMorgan strategists, who raised their share increase recommendation from 8 percent to 10 percent, reduced their buying positions in private sector bonds.
Recently, the coronavirus vaccine developed by the US Pfizer and German BioNTech companies gave 90 percent positive results, and the markets experienced a rapid movement after this development.
On the other hand,
European Central Bank President Christine Lagarde, Bank of England President Andrew Bailey and
FED President Jerome Powell stated that they do not expect the good news about the coronavirus vaccine to reverse the bad effects of the epidemic in an instant.